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Background: Blood group O protects African children against severe malaria and has reached high prevalence in
malarious regions. However, its role in malaria in pregnancy is ambiguous. In 839 delivering Ghanaian women,
associations of ABO blood groups with Plasmodium falciparum infection were examined.
Methods: Plasmodium falciparum infection was diagnosed in placental blood samples by microscopy and PCR
assays. Present or past infection was defined as the detection of parasitaemia or haemozoin by microscopy, or a
positive PCR result. Blood groups were inferred from genotyping rs8176719 (indicating the O allele) and rs8176746/
rs8176747 (distinguishing the B allele from the A allele).
Results: The majority of women had blood group O (55.4%); present or past P. falciparum infection was seen in
62.3% of all women. Among multiparae, the blood groups had no influence on P. falciparum infection. In contrast,
primiparae with blood group O had significantly less present or past infection than women with non-O blood
groups (61.5 vs 76.2%, P = 0.007). In multivariate analysis, the odds of present or past placental P. falciparum infection
were reduced by 45% in blood group O primiparae (aOR, 0.55 [95% CI, 0.33–0.94]).
Conclusions: The present study shows a clear protective effect of blood group O against malaria in primiparae.
This accords with findings in severe malaria and in vitro results. The data underline the relevance of host genetic
protection among primiparae, i.e. the high-risk group for malaria in pregnancy, and contribute to the understanding
of high O allele frequencies in Africa.Background
Plasmodium falciparum malaria has long been suggested
to influence the global distribution of the ABO blood
groups [1], similar to the selection of the malaria-
protective sickle cell gene in endemic regions [2]. In fact,
blood group O is particularly common in malarious re-
gions, e.g. sub-Saharan Africa [3,4], and confers protec-
tion against potentially fatal severe malaria across
African populations [5-8]. In addition, various in vitro
observations and functional hypotheses support a pro-
tective role of blood group O (reviewed by [3,4,9]).
In contrast, findings are notably ambiguous with re-
spect to the impact of the ABO system on malaria in
pregnancy. Pregnant women – particularly primiparae –
are a high risk group for P. falciparum infection and* Correspondence: frank.mockenhaupt@charite.de
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article, unless otherwise stated.malaria. In areas of high transmission, malaria in preg-
nancy is frequently asymptomatic but consequences
involve anaemia, abortion, stillbirth, low birth weight
(LBW), preterm delivery (PTD), and, annually, up to
200,000 infant deaths [10]. In pregnant women, specific
expression variants of the parasite’s P. falciparum
erythrocyte membrane protein-1 (PfEMP1) mediate ad-
hesion to the placental syncytiotrophoblast (the epithe-
lial lining of the intervillous space) and thereby placental
sequestration of infected erythrocytes, deposition of hae-
mozoin (malaria pigment), and, commonly, the local accu-
mulation of inflammatory cells [11]. In highly endemic
regions, specific immunity against these pregnancy-
associated parasites is particularly low in primigravidae,
and acquired only with successive pregnancies, which goes
along with declining infection prevalence and clinical
manifestation [10-12]. In The Gambia and Malawi, blood
group O was associated with increased odds of placental
malaria in primiparae but with a reduced risk intral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/4.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
Table 1 ABO genotypes in 827 delivering Ghanaian women
Phenotype Genotype No (%)
O O O* 458 (55.4)
B B O 169 (20.4)
B B 18 (2.2)
A A O 136 (16.4)
A A 13 (1.6)
AB A B 33 (4.0)
*, includes genotypes OO24 (n = 30), O24O24 (n = 1), and O2O2 (n = 1).
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cental infection were associated in both primi- and mul-
tiparae [15]. In contrast, a Gabonese study reported a
trend towards less placental malaria in blood group O
women [16], and in a recent prospective study from
Thailand, no association at all between ABO blood groups
and malaria during pregnancy was observed [17]. Against
this background of conflicting results, the present study
aimed at examining the influence of blood group O on
P. falciparum infection among pregnant women in
hyper- to holo-endemic Ghana using PCR for blood
group genotyping.
Methods
Eight-hundred and thirty-nine women with live single-
ton delivery were recruited from January 2000 through
January 2001 at the Presbyterian Mission Hospital in
Agogo, Ghana. The study protocol was approved by the
Committee on Human Research Publications and Ethics,
School of Medical Sciences, University of Science and
Technology, Kumasi, and informed written consent was
obtained from all women. Agogo is a community of
some 30,000 inhabitants located in the forested hills of
Asante Akim North District. Subsistence farming, trade
and mining are the main income sources in that region,
and malaria is hyper- to holo-endemic [18]. Study proce-
dures and the characteristics of the largely asymptomatic
participants have been described in detail elsewhere [12].
In brief, women were clinically examined, socio-economic
data documented, and intervillous and venous blood sam-
ples were collected into EDTA. Malaria parasites in post-
delivery placental and venous samples were counted
microscopically on Giemsa-stained thick blood films per
100 high-power fields and 500 white blood cells, respect-
ively. Placental parasite densities were expressed as
parasites/100 fields and peripheral ones as parasites/μL as-
suming a mean white blood cell count of 8,000/μL.
Leukocyte-associated haemozoin in placental samples was
recorded. Following DNA extraction (QIAmp, Qiagen,
Hilden, Germany), nested P. falciparum-specific PCR as-
says were performed [19]. Present or past placental P. fal-
ciparum infection was defined as the presence of placental
parasitaemia or haemozoin by microscopy, or a positive P.
falciparum PCR result on placental samples. Plasma con-
centrations of pyrimethamine, at that time recommended
for malaria chemoprophylaxis in pregnancy, and of
chloroquine were measured by ELISA assays [20] with
limits of detection of 10 ng/mL and 5 ng/ml, respectively.
Haemoglobin (Hb) was measured by a HemoCue pho-
tometer (Ångelholm, Sweden). Anaemia was defined as
Hb <11 g/dL. Birth weight and gestational age were
assessed within 24 hours after delivery. LBW was defined
as a birth weight <2500 g. PTD was defined as a gesta-
tional age <37 weeks applying the Finnström score whichcorrectly estimates gestational age (±3 weeks) in >95% of
infants [21].
Three loci on the ABO gene, namely rs8176719,
rs8176746, and rs8176747 were typed by melting curve
analysis employing the LightCycler 480 device (Roche
Diagnostics, Mannheim, Germany) and using commer-
cially available primers and probes (TIB Molbiol, Berlin,
Germany). ABO blood groups were inferred from
rs8176719 (indicating the O allele) and from rs8176746/
rs8176747 (distinguishing the B allele from the A allele)
[22]. In case of ambiguous typing results (n = 38), PCR-
generated fragments containing the polymorphisms of
interest were subjected to sequencing (Eurofins, Berlin,
Germany).
Continuous variables were compared between groups
by t-test, analysis of variance, Mann–Whitney U-test,
and Kruskal-Wallis test as applicable. Associations of
blood groups with P. falciparum infection, anaemia,
LBW, and PTD were identified by χ2-test, and odds ra-
tios (ORs) and 95% confidence intervals (95% CIs) calcu-
lated. Adjusted ORs (aORs) were derived from logistic
regression models with stepwise backward removal of
factors not associated in multivariate analysis (P > 0.05).
For placental malaria, previously identified associated
factors were a priori included, i.e. delivery in rainy season,
age and plasma pyrimethamine concentrations [12]. A
P-value of <0.05 was considered statistically significant.
Results
ABO genotyping was successful in 827 of 839 (98.6%)
women with a live singleton delivery. The majority of
women (55.4%) had blood group O. Blood groups B, A,
and AB were present in 22.6, 18.0, and 4.0%, respect-
ively. Blood groups were in Hardy-Weinberg equi-
librium; genotypes are detailed in Table 1. Plasma
concentrations of pyrimethamine, representing chemo-
prophylaxis, were observed in 36.0% (163/453) of
women with blood group O, and in 33.3% (119/357) of
women with non-O blood groups (P = 0.43; chloroquine
plasma concentrations, 24.3% (110/453) vs. 20.2% (72/
357), P = 0.16).
Evidence of present or past P. falciparum infection
in placental samples (parasitaemia or haemozoin by
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seen in 62.3% (515/827) of all women. This figure was sig-
nificantly lower in women with blood group O (59.0%,
270/458) than in women with non-O blood groups
(66.4%, 245/369; P = 0.03). Notably, this difference was
pronounced among primiparae (61.5% vs. 76.2%, P =
0.007) but insignificant among multiparae (Table 2). Fur-
ther analysis therefore focused on the 300 primiparous
women. Among these, the prevalence of infection (regard-
less of diagnostic tool) appeared to be lower in women
with blood group O than in any of the non-O blood
groups. Based on parasite detection by microscopy, this
difference was only small. Likewise, neither placental nor
peripheral blood parasite densities correlated with the
blood groups (e.g., placental parasite densities in blood
group O versus non-O primiparae: 127 (95% CI, 74–216)
vs. 102 (51–204) parasites/100 high-power fields, P =
0.63). In contrast, the reduced infection prevalence among
blood group O primiparae was obvious taking into ac-
count PCR results, and even more so when considering
placental haemozoin (Table 3). In multivariate analysis,
the odds of present or past placental P. falciparum infec-
tion were reduced by 45% in primiparae with blood group
O (Table 3), adjusting for known predictors of placental
infection in this group [12], i.e. years of age (aOR, 0.92
[95% CI, 0.86–0.99]), delivery in the rainy season (aOR,
1.76 [95% CI, 1.06–2.92]), and presence of pyrimethamine
in plasma (indicating compliance with chemoprophylaxis;
aOR, 0.60 [95% CI, 0.35–1.00]). Breakdown by placental
infection status [23] revealed that blood group O tended
to protect particularly against late infections (both para-
sites and pigment present), while - combining microscopy
and PCR results - the impact on microscopic (i.e. visible
parasites) and submicroscopic infections (i.e. detectable by
PCR only) was similar (Table 3).
Small numbers prevented a meaningful attribution of
infection risks to individual genotypes. Nevertheless,Table 2 Prevalence of Plasmodium falciparum infection accord
Blood group, primiparae
O Non-O
All B A
No. 174 126 72 4
P. falciparum infection, placental blood (%)
Microscopy positive 42.5 50.0 52.8 4
Haemozoin positive 36.2 50.8* 52.8* 5
PCR positive 60.3 70.6 65.3 7
Any positive finding† 61.5 76.2* 69.4 8
P. falciparum infection, peripheral blood (%)
Microscopy positive 24.1 29.4 33.3 2
PCR positive 54.6 65.1 62.5 6
*Comparison to blood group O, P < 0.05; †, parasitaemia or haemozoin by microscopresent or past placental infection was observed in
88.9% (16/18) of primiparae with homozygous non-O
genotypes, in 74.1% (80/108) of O-heterozygous women,
and in 61.5% (107/174) of first-time delivering women
with blood group O (c2 trend = 8.7, P = 0.003). Corres-
pondingly, the O allele was significantly less frequent in
primiparae with present or past placental infection than
in those without (0.72 vs 0.84, P = 0.003).
In multiparae, none of the above malaria-protective fea-
tures of blood group O were discernible; blood group A
even tended to come along with lower infection preva-
lence (Table 2). Particularly, already in secundiparae,
present or past placental infection occurred at similar
prevalence in women with blood group O and in the non-
O group (66.0% (70/106) vs 69.2% (54/78), P = 0.65).
Blood group O was furthermore associated with re-
duced odds of maternal anaemia among all women, and
among primiparae in particular (Table 4). This was due
to the difference in women without placental malaria, i.e.
only 10.5% (7/67) of non-malarious blood group O prim-
iparae in this group were anaemic as compared to 33.3%
(10/30) of their non-O peers (P = 0.006) whereas the dif-
ference was small and not significant among primiparae
with evidence of present or past infection (44.9%, 48/107
vs 52.1%, 50/96, P = 0.30). Likewise, the proportions of
malaria-associated LBW or preterm delivery did not differ
significantly between O and non-O blood groups, neither
in primiparae nor in multiparae.
Discussion
In the present study from Ghana, almost two in three
women had evidence of present or past placental P. fal-
ciparum infection. In this highly endemic setting, blood
group O was associated with protection against placental
malaria among primiparae but not in multiparae, and
particularly against late or chronic infections, i.e., infec-
tions characterized by the presence of pigment. Thising to blood group and parity
Blood group, multiparae
O Non-O
AB All B A AB
6 8 283 237 111 102 24
3.5 62.5 30.0 27.0 31.5 21.6 29.2
0.0 37.5 24.0 24.9 28.8 17.6 37.5
6.1* 87.5 55.5 58.2 60.4 54.9 62.5
4.8* 87.5 57.6 61.6 64.0 57.8 66.7
6.1 12.5 17.0 11.4 14.4 8.8* 8.3
9.6 62.5 50.5 49.4 52.3 45.1 54.2
py, or positive PCR. Parity data were missing for seven women.
Table 3 Placental Plasmodium falciparum infection in primiparae separated by blood group O (n = 174) vs non-O blood
groups (n = 126)
Placental infection status Blood group OR (95% CI) P aOR* (95% CI) P
O Non-O
Microscopy positive (%) 42.5 50.0 0.74 (0.45-1.20) 0.20 0.80 (0.49-1.28) 0.35
Haemozoin positive (%) 36.2 50.8 0.55 (0.34-0.90) 0.01 0.61 (0.37-0.98) 0.04
PCR positive (%) 60.3 70.6 0.63 (0.38-1.06) 0.07 0.68 (0.41-1.13) 0.14
Any positive finding (%)† 61.5 76.2 0.50 (0.29-0.86) 0.007 0.55 (0.33-0.94) 0.03
Microscopic infection status (%)
Pigment only 5.2 8.7 0.47 (0.16-1.32) 0.11 0.62 (0.23-1.67) 0.35
Pigment plus parasites 31.0 42.1 0.58 (0.34-1.0) 0.04 0.64 (0.38-1.09) 0.10
Parasites only 11.5 7.9 1.14 (0.46-2.85) 0.75 1.33 (0.55-3.20) 0.52
PCR-based infection status (%)
Submicroscopic 17.8 22.2 0.56 (0.28-1.14) 0.08 0.59 (0.30-1.14) 0.12
Microscopic 42.5 50.0 0.60 (0.34-1.04) 0.05 0.64 (0.37-1.11) 0.12
Odds ratios are calculated against the respective non-infected reference group.
*Adjusted for age, rainy season, and presence of pyrimethamine in plasma (indicating intake of chemoprophylaxis).
†Parasitaemia or haemozoin by microscopy, or positive PCR.
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group O in severe malaria [5-8] and the moderately
beneficial impact of blood group O in many studies on
uncomplicated malaria (reviewed by [3,4,9]). Severe
childhood malaria and malaria in pregnancy differ
largely in terms of pathophysiology, immunity and clin-
ical manifestation [10-12], but primiparae to some ex-
tent resemble young children with respect to a lack or
an insufficient degree of protective immune mechanisms
against P. falciparum. In pregnant women, P. falcip-
arum-infected erythrocytes sequester in the intervillous
space by adhering to ligands on the syncytiotrophoblast,
followed by the local accumulation of haemozoin and in-
flammatory cells. Specific antibodies capable of blocking
parasite adhesion prevent this placental malaria only
after successive pregnancies exposed to P. falciparum in-
fection [11,24,25]. This likely explains why protection
against P. falciparum infection due to blood group O in
the present study was limited to the relatively immune-
naïve group of primiparae. At higher parity, the effects
of adaptive immunity may override the protection
afforded by blood group O.
Notably, however, two studies from The Gambia and
Malawi have reported results contrasting the present
finding, i.e. an increased risk of active placental malariaTable 4 Anaemia, low birth weight, and preterm delivery sep
Parameter All Primipar
Blood group O Non-O blood groups O
Anaemia (%, n/n) 31.7 (145/458) 39.6 (146/369)* 31.6 (55/1
LBW (%, n/n) 14.6 (67/458) 17.9 (66/369) 23.0 (40/1
PTD (%, n/n) 17.8 (81/454) 20.3 (74/365) 24.7 (43/1
*, P = 0.02; †, P = 0.005.in blood group O primiparae and a reduced risk in mul-
tiparae [13,14]. The reason for this disagreement is un-
clear but may involve the classification of placental
malaria by histopathological diagnosis in these previous
studies and by blood film microscopy and PCR in the
present. Remarkably, in both previous studies, past in-
fections (presence of pigment only) tended to be re-
duced in blood group O primiparae. In the present
study, much of the observed associations was based on
the lowered presence of haemozoin but microscopically
visible parasites also tended to be reduced in group O
primiparae (Table 3). Sensitive PCR assays in the present
study, considered to detect only viable parasites [26],
only shifted this difference between blood groups to a
higher prevalence level and, interestingly, the reduced
infection rate in blood group O primiparae was observed
for both microscopic and submicroscopic infections.
This is in line with the lack of effect of the blood groups
on parasite density observed in the present study. Part
of the conflicting results with and between previous
studies may result from small samples sizes [13,15,16] as
well as from low prevalence of infection [15-17] in previ-
ous studies. Notably, however, in one small study from
Gabon, blood group O tended to protect against placen-
tal malaria, with a larger effect in primiparae than inarated by blood group and parity
ae Multiparae
Non-O blood groups O Non-O blood groups
74) 47.6 (60/126)† 31.8 (90/283) 35.9 (85/237)
74) 30.2 (38/126) 9.5 (27/283) 11.4 (27/237)
74) 28.6 (36/126) 13.6 (38/279) 15.8 (37/234)
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weekly malaria screening by peripheral blood films did
not show any effect of the ABO blood groups on malaria
episodes (occurring in 30% of women) [17]. However,
peripheral blood film microscopy in pregnant women
has a notoriously poor sensitivity [27], only 1% of pla-
centas were malaria positive, and the majority of malaria
episodes were due to Plasmodium vivax. Therefore, it is
questionable whether these findings from Thailand can
be compared with the African studies. Blood group O in
the present study was also associated with reduced odds
of anaemia, particularly in primiparae. Protection from
malaria-related anaemia in individuals with blood group
O has been observed before [28] but, remarkably, this
was not the case in the present study, in which, rather,
anaemia was less common among non-infected blood
group O women. This finding may reflect the cumulative
effect over time of reduced malaria in blood group O
primiparae. Longitudinal studies will be needed to ad-
dress this question.
As a limitation of the present study, protection by
blood group O was statistically significant only when
considering placental haemozoin or when combining re-
sults of all diagnostic means (although microscopic data
showed accordant trends). Statistically significant find-
ings were observed in the relatively small group of 300
primiparae of whom 174 had blood group O. The study
was sufficiently powered to detect an influence of blood
group O on present or past infection but power declined
with declining diagnostic sensitivity, i.e. prevalence of in-
fection. Limited sample sizes in subgroups may thus
have interfered with the analysis of infection risks in in-
dividual genotypes and of potential modification of
malaria-related outcomes, e.g., LBW. Also, data on some
potentially interfering factors were not available, e.g.,
bed net use or transfusions. This should be kept in mind
when interpreting the data.
The hypotheses on why blood group O protects from
malaria, and from severe malaria in particular, include
aspects of differential attractiveness to Anopheles vec-
tors, shared ABO antigens with P. falciparum, impaired
merozoite penetration as well as reduced cyto-adherence
(reviewed by [3,4,9]). The A and B antigens are erythro-
cyte surface trisaccharides [22] and receptors for roset-
ting, i.e. the binding of P. falciparum-infected red blood
cells (RBCs) to uninfected erythrocytes (an in vitro sign
of parasites causing severe malaria) [5]. Binding of the
parasite ligand, PfEMP1, to the A antigen has been
shown [29]. In blood group O, the disaccharide H anti-
gen is produced instead of A and B antigens [22], and P.
falciparum-infected RBCs form smaller and less firm ro-
settes than in non-O RBCs [29]. In fact, the protective
effect of blood group O against severe malaria has been
shown to operate through the mechanism of reduced P.falciparum rosetting [5]. However, rosetting is rarely ob-
served in placental P. falciparum isolates [30] and the
PfEMP1 domain mediating binding to ligands on the
syncytiotrophoblast differs from the binding domain
involved in rosetting [29,31,32]. Nevertheless, ABO-
dependent differences in cyto-adherence may still be
relevant in placental malaria (reviewed by [4]): The mol-
ecules on the syncytiotrophoblast to which pregnancy-
specific P. falciparum strains bind, i.e. chondroitin
sulphate A (CSA) and hyaluronic acid [33,34], are struc-
turally related to the A antigen which gives rise to the
possibility that adhesion of infected RBCs to the syncy-
tiotrophoblast may be influenced by ABO polymor-
phisms. Also, the placental proteoglycan thrombomodulin
mediates part of the binding of infected RBCs [35].
Thrombomodulin and other molecules involved in cyto-
adhesion, e.g., von Willebrandt factor, are affected by the
ABO phenotype [36]. Recently, enhanced macrophage-
mediated phagocytosis of P. falciparum-infected O-RBCs
has been shown [37]. Considering that many women with
placental malaria show a substantial inflammatory infil-
trate in the intervillous space, composed mainly of mono-
cytes and macrophages [38], ABO-dependent clearance of
infected RBCs could partially explain the finding of the
present study of less placental malaria in women with
blood group O.
Conclusion
The present study demonstrates a protective influence of
blood group O against P. falciparum infection in prim-
iparae living in an area of high malaria endemicity. Con-
sidering the consequences of placental malaria in terms of
infant mortality, the influence of the ABO polymorphism
on malaria in pregnancy may contribute to the high fre-
quencies of the O allele in sub-Saharan Africa.
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